Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Margit
Margit Bauer, Biberach DE
| Patent application number | Description | Published |
|---|---|---|
| 20080293680 | Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II - The invention relates to a compound of the formula (I), wherein R | 11-27-2008 |
Margit Bukohl, Marl DE
| Patent application number | Description | Published |
|---|---|---|
| 20110054080 | METHOD FOR PRODUCING COATED RUBBER PARTICLES AND COATED RUBBER PARTICLES - The method describes a novel production method for coated particles made of rubber granules, the coating, the particles thus coated, and the use of the coated particles. | 03-03-2011 |
| 20110305850 | METHOD FOR THE PRODUCTION OF COATED RUBBER PARTICLES, COATED RUBBER PARTICLES, AND SOLVENT-FREE COATING FORMULATION - The invention describes a novel production process for coated particles composed of granulated-rubber material, the coating, the particles coated therewith and the uses of the coated particles. The coating formulation is solvent-free. | 12-15-2011 |
Margit Doth, Leverkusen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110207778 | Active compound combination comprising azadirachtin and a substituted enaminocarbonyl compound - Disclosed are novel active compound combinations comprising at least one substituted enaminocarbonyl compound and azadirachtin, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids. Methods of controlling insects and acarids are also disclosed. | 08-25-2011 |
Margit Hölzl, Vorchdorf AT
| Patent application number | Description | Published |
|---|---|---|
| 20100077918 | CYLINDER FOR HIGH-PRESSURE HYDRAULICS - A cylinder for high-pressure hydraulics is disclosed, with a cylinder sleeve extending between a cylinder base and a cylinder head composed of an inner tube and an outer sleeve made from fiber-reinforced plastic placed on the inner tube. According to the invention, a weight reduction without loss of rigidity may be achieved, whereby the inner tube of the cylinder sleeve screwed to the cylinder base and joined to the outer sleeve in a thrust-resistant or shear-resistant manner engages with the cylinder head in a tensile-resistant manner. | 04-01-2010 |
Margit Hornof, Vienna AT
| Patent application number | Description | Published |
|---|---|---|
| 20100028399 | Use of Polymers - The present invention relates to the use of a thiol-group-containing polymer for preparing an implant for tissue augmentation, wherein the basis polymer is a polysaccharide. | 02-04-2010 |
Margit Kakas, Karlstein DE
| Patent application number | Description | Published |
|---|---|---|
| 20100203173 | SILICA DISPERSION - Dispersion containing, in addition to water, 0.5 to 20% by weight of hydrophobic silica, 0.01 to 10% by weight of a gelling additive, or viscosity-increasing additive which, as further components, contains at least one phenol or at least one phenol derivative and/or at least one aldehyde. It is prepared by dispersing the individual components successively or together in water, in which case the individual components are deaerated before and/or during the addition or the dispersion is deaerated during the individual dispersion steps and thereafter the residual air present in the dispersion is removed by application of vacuum. The dispersion can be used as insecticide and for controlling pathogenic agents. | 08-12-2010 |
Margit Mahlapuu, Goteborg SE
| Patent application number | Description | Published |
|---|---|---|
| 20080267933 | Probiotics to Influence Fat Metabolism and Obesity - Use of probiotic bacteria for the manufacture of a food product, feed product, dietary supplement, nutritional product, natural remedy, pharmaceutical active formulation and medicinal product to be used for controlling weight gain, preventing obesity, increasing satiety, prolonging satiation, reducing food intake, reducing fat deposition, improving energy metabolism, enhancing insulin sensitivity, treating obesity and treating insulin insensitivity. The probiotic bacteria is at least one of | 10-30-2008 |
| 20110306565 | HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION - Pharmaceutical compositions are provided for enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions. | 12-15-2011 |
Margit Pfundstein, Weingarten DE
| Patent application number | Description | Published |
|---|---|---|
| 20110135849 | MULTILAYERED ELEMENTS, THE PRODUCTION THEREOF AND THE USE THEREOF - Multilayered articles comprise | 06-09-2011 |
Margit Rajamäki, Pori FI
| Patent application number | Description | Published |
|---|---|---|
| 20110278495 | PROCESS OF PREPARING ALKALI METAL TITANATES - A lithium titanate product, the formula of which is in the form of Li | 11-17-2011 |
Margit Steiner-Langlechner, Altoetting DE
| Patent application number | Description | Published |
|---|---|---|
| 20120123143 | METHOD FOR PRODUCING ALKOXY-SUBSTITUTED 1,2-BISSILYLETHANES - The invention relates to a method for producing alkoxy-substituted 1,2-bissilylethanes of the general formula 1 | 05-17-2012 |
Margit Teltschik, Karlstadt DE
| Patent application number | Description | Published |
|---|---|---|
| 20080248428 | Method for Producing Flexographic Printing Forms by Thermal Development - The invention relates to a method for producing flexographic printing forms by thermal development during which a flexographic printing element exposed in an image-like manner is developed by heating and removing the softened, non-polymerized portions of the relief-forming layer, whereby the flexographic printing element used contains a styrene butadiene block copolymer mixed with a softener, and the proportion of butadiene which is 1,2-coupled, ranges from 15 to 50% by weight of the block copolymer. | 10-09-2008 |
Margit Villing, Nieul Le Dolent FR
| Patent application number | Description | Published |
|---|---|---|
| 20100303210 | PHANTOM OBJECT FOR THE QUALITY CONTROL OF A DEVICE FOR RADIATION THERAPY TREATMENT AND METHODS FOR ITS MANUFACTURE AND ITS USE - This phantom object is designed for a Winston-Lutz test on a device for radiation therapy treatment comprising a patient support having a rotation axis (V), a stand having a rotation axis (H) and a collimator having a rotation axis (C), locating means being provided for visually representing the theoretical positions (V′, H′, C′) of the three axes (V, H, C). A spherical ball is positioned at the center of a sphere in a material of electron density lower than that of the ball, the ball and the sphere both constituting the phantom object. The sphere has on its outer surface means for a visual alignment with the locating means allowing a positioning of the phantom object at the point of convergence of the three axes (V′, H′, C′). | 12-02-2010 |
Margit Weghofer, Vienna AT
| Patent application number | Description | Published |
|---|---|---|
| 20090104208 | House Dust Mite Allergen - A polypeptide comprising an amino acid sequence having at least 60% identity to the amino acid sequence SEQ ID No. 1 or comprising at least one amino acid fragment of at least 6 consecutive amino acid residues of the amino acid sequence SEQ ID No. 1 or having immunological cross-reactivity to the amino acid sequence SEQ ID No. 1 or fragments thereof, wherein the amino acid sequence SEQ ID No. 1 codes for an allergen and the polypeptide comprises at least one T cell epitope recognized by a T cell receptor specific for a molecule having the amino acid sequence SEQ ID No. 1. | 04-23-2009 |
Margit Wissenbach, Fredensborg DK
| Patent application number | Description | Published |
|---|---|---|
| 20090318362 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION - Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof. | 12-24-2009 |
| 20100292311 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION - Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof. | 11-18-2010 |
| 20120088907 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION - Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof. | 04-12-2012 |